Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Henry, Wei"'
Autor:
Muayad Hamidi, Eric L. Eisenstein, Maryam Y. Garza, Kayla Joan Torres Morales, Erika M. Edwards, Mitra Rocca, Amy Cramer, Gurparkash Singh, Kimberly A. Stephenson-Miles, Mahanaz Syed, Zhan Wang, Holly Lanham, Rhonda Facile, Justine M. Pierson, Cal Collins, Henry Wei, Meredith Zozus
Publikováno v:
Journal of Clinical and Translational Science, Vol 8 (2024)
Abstract Introduction: The value of Source Data Verification (SDV) has been a common theme in the applied Clinical Translational Science literature. Yet, few published assessments of SDV quality exist even though they are needed to design risk-based
Externí odkaz:
https://doaj.org/article/5532d1ca88c549afa9f46a117d9efb22
Autor:
Wawa, Leung, Henry Wei
Publikováno v:
World Literature Today, 2019 Apr 01. 93(2), 71-71.
Externí odkaz:
https://www.jstor.org/stable/10.7588/worllitetoda.93.2.0071
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-16 (2020)
Abstract Background Monoclonal antibodies (mAbs) have been used for cancer therapy. They are large and have some disadvantages limiting their use. Smaller antibody fragments are needed as their alternatives. A fully human single-domain antibody (sdAb
Externí odkaz:
https://doaj.org/article/d1dcbfbf9b3d424aa915ac6e0024a43f
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Monoclonal antibodies (mAbs) are large and have limitations as cancer therapeutics. Human single-chain variable fragment (scFv) is a small antibody as a good alternative. It can easily enter cancer tissues, has no immunogenicity and can be produced i
Externí odkaz:
https://doaj.org/article/2d91a21b1d5e4024be2b528398e454b5
Autor:
Leung, Henry Wei
Publikováno v:
Fourth Genre, 2016 Oct . 18(2), 61-76.
Externí odkaz:
https://www.jstor.org/stable/10.14321/fourthgenre.18.2.0061
Publikováno v:
The New Zealand medical journal. 135(1567)
To ascertain if endoscopic retrograde cholangiopancreatography (ERCP) in the elderly is associated with an increased risk of complications.Retrospective study of 509 consecutive ERCPs on 338 patients in one year (2019-2020). Patients were categorised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4cd65dc372d019f3c6526d1e36518479
https://pubmed.ncbi.nlm.nih.gov/36521083
https://pubmed.ncbi.nlm.nih.gov/36521083
Autor:
Oriana, Munevar Aquite, Michael, Hayes, Kebede, Beyene, Amy Hai Yan, Chan, Cameron, Schauer, Henry, Wei, Jiayi, Gong
Publikováno v:
The New Zealand medical journal. 135(1563)
The safety of dabigatran is poorly studied in patients with liver cirrhosis and has rarely been compared to warfarin in terms of bleeding risks.We undertook a retrospective cohort study across three tertiary centres in Auckland, New Zealand, between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3d5f5a0d5c26a8fdebaeb85e72050178
https://pubmed.ncbi.nlm.nih.gov/36201730
https://pubmed.ncbi.nlm.nih.gov/36201730
Autor:
Henry Wei, Lauren Jane Child
Publikováno v:
World Journal of Hepatology
BACKGROUND Conventional coagulation tests are widely used in chronic liver disease to assess haemostasis and to guide blood product transfusion. This is despite the fact that conventional tests do not reliably separate those with a clinically signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eccf2abfee150d7e2e48d7b86ce5e03
http://europepmc.org/articles/PMC7701961
http://europepmc.org/articles/PMC7701961
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-16 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Monoclonal antibodies (mAbs) have been used for cancer therapy. They are large and have some disadvantages limiting their use. Smaller antibody fragments are needed as their alternatives. A fully human single-domain antibody (sdAb) has a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f58da40ca2303503bbba0959d6d744
http://link.springer.com/article/10.1186/s12967-020-02538-y
http://link.springer.com/article/10.1186/s12967-020-02538-y
Autor:
Cameron, Schauer, Anurag, Sekra, Ibrahim, Hassan, Yi-Ting, Wu, Michael Tm, Wang, Henry, Wei, David, McGouran, Ming Han, Lim, Dinesh, Lal, Ravinder, Ogra
Publikováno v:
The New Zealand medical journal. 134(1545)
Patients with incurable oesophageal cancer have poor outcomes, with disabling symptoms and a poor quality of life (QOL), which may be improved by oesophageal stenting. We aimed to measure change in symptoms related specifically to oesophageal cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60ee8cb6fb754e21520e08288cf2c8d6
https://pubmed.ncbi.nlm.nih.gov/34788276
https://pubmed.ncbi.nlm.nih.gov/34788276